Breaking News Instant updates and real-time market news.

2020-02-26 06:51:56 MGNX MacroGenics $11.01 / -0.03 (-0.27%) 06:51 02/26/20 02/26 06:51 02/26/20 06:51	MacroGenics price target lowered to $15 from $18 at Citi Citi analyst Yigal Nochomovitz lowered the firm's price target on MacroGenics to $15 from $18 and keeps a Buy rating on the shares. MacroGenics remains under pressure from uncertainty surrounding the company's late-stage pipeline, Nochomovitz tells investors in a research note. While margetuximab's Biologics License Application acceptance was expected, uncertainty on its commercial prospects remain, says the analyst. Nochomovitz, however, believes multiple readouts from the early-stage pipeline should help the stock work in 2020.	26 Feb
MGNX MacroGenics $11.01 / -0.03 (-0.27%) 12/19/19 Fly Intel: Top five analyst initiations 12/19/19 Cantor Fitzgerald Cantor starts MacroGenics with Overweight rating, $17 price target 12/18/19 Cantor Fitzgerald MacroGenics initiated with an Overweight at Cantor Fitzgerald 12/12/19 BTIG MacroGenics price target lowered to $23 from $30 at BTIG

2020-02-26 06:51:56

MGNX

MacroGenics

$11.01 / -0.03 (-0.27%)

06:51

02/26/20

02/26

06:51

02/26/20

06:51

MacroGenics price target lowered to $15 from $18 at Citi

Citi analyst Yigal Nochomovitz lowered the firm's price target on MacroGenics to $15 from $18 and keeps a Buy rating on the shares. MacroGenics remains under pressure from uncertainty surrounding the company's late-stage pipeline, Nochomovitz tells investors in a research note. While margetuximab's Biologics License Application acceptance was expected, uncertainty on its commercial prospects remain, says the analyst. Nochomovitz, however, believes multiple readouts from the early-stage pipeline should help the stock work in 2020.

26
Feb

MGNX MacroGenics

$11.01 / -0.03 (-0.27%)

12/19/19: Fly Intel: Top five analyst initiations

12/19/19 Cantor Fitzgerald: Cantor starts MacroGenics with Overweight rating, $17 price target

12/18/19 Cantor Fitzgerald: MacroGenics initiated with an Overweight at Cantor Fitzgerald

12/12/19 BTIG: MacroGenics price target lowered to $23 from $30 at BTIG

TODAY'S FREE FLY STORIES

Syndicate	Morphic 3.5M share Secondary priced at $70.00 » 20:27 03/02/21 03/02 20:27 03/02/21 20:27 MORF Morphic $70.99 / -13.82 (-16.30%) The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) 03 Mar MORF Morphic $70.99 / -13.82 (-16.30%) 16:48 Today Fly Intel: Wall Street's top stories for Tuesday 12:25 Today Fly Intel: Wall Street's top stories at midday 09:00 Today Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers
Conference/Events	Digi International participates in a conference call with Piper Sandler » 20:05 03/02/21 03/02 20:05 03/02/21 20:05 DGII Digi International $23.50 / -0.92 (-3.77%) Group investor conference… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events DGII Digi International $23.50 / -0.92 (-3.77%) 11/12/20 Digi International says not giving guidance, cites pandemic DGII Digi International $23.50 / -0.92 (-3.77%) 02/04/21 Roth Capital Digi International price target raised to $29 from $22 at Roth Capital 02/04/21 Lake Street Digi International price target raised to $25 from $21 at Lake Street 02/04/21 Craig-Hallum Digi International price target raised to $28 from $22 at Craig-Hallum 01/07/21 Sidoti Digi International downgraded to Neutral from Buy at Sidoti DGII Digi International $23.50 / -0.92 (-3.77%) 02/03/21 Digi International reports Q1 EPS0 32c, consensus 6c 11/12/20 Digi International reports Q4 adjusted EPS 32c, consensus 9c 04 Mar DGII Digi International $23.50 / -0.92 (-3.77%) 11/12/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 03/03/21 Digi International - DGII
Conference/Events	Nurix Therapeutics participates in a conference call with JPMorgan » 20:03 03/02/21 03/02 20:03 03/02/21 20:03 NRIX Nurix Therapeutics $35.87 / -0.305 (-0.84%) Group investor conference… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events NRIX Nurix Therapeutics $35.87 / -0.305 (-0.84%) 01/07/21 Nurix Therapeutics expands strategic collaboration with Sanofi 10/26/20 Nurix appoints Robert Tjian as chairman of Scientific Advisory Board NRIX Nurix Therapeutics $35.87 / -0.305 (-0.84%) 02/17/21 Piper Sandler Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler 02/16/21 Piper Sandler Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler 01/29/21 JPMorgan Nurix Therapeutics price target raised to $56 from $34 at JPMorgan 11/24/20 Morgan Stanley Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley NRIX Nurix Therapeutics $35.87 / -0.305 (-0.84%) 02/16/21 Nurix Therapeutics reports Q4 EPS (51c), consensus (54c) 10/14/20 Nurix Therapeutics reports Q3 EPS (59c), consensus (41c) 05 Mar 24 Jul 03/16/21 31st Annual Healthcare Virtual Conference 03/03/21 Nurix Therapeutics - NRIX
Upgrade	Sage Group upgraded to Neutral from Sell at Goldman Sachs » 19:41 03/02/21 03/02 19:41 03/02/21 19:41 SGPYY Sage Group $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research SGPYY Sage Group $0.00 / + (+0.00%) 01/14/21 Sage Group says AgeMark moves to Sage Intacct solution 12/16/20 Sage announces Sage Partner Cloud Program in the U.S., Canada SGPYY Sage Group $0.00 / + (+0.00%) 02/19/21 Credit Suisse Sage Group price target raised to 547 GBp from 500 GBp at Credit Suisse 01/25/21 UBS Sage Group upgraded to Neutral from Sell at UBS 01/22/21 Credit Suisse Sage Group price target lowered to 500 GBp from 530 GBp at Credit Suisse 01/22/21 Peel Hunt Sage Group initiated with a Buy at Peel Hunt
Syndicate	Magnolia Oil & Gas 17M share Spot Secondary priced at $10.50 » 19:33 03/02/21 03/02 19:33 03/02/21 19:33 MGY Magnolia Oil & Gas $11.84 / -0.23 (-1.91%) The deal prices at low… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate MGY Magnolia Oil & Gas $11.84 / -0.23 (-1.91%) 02/22/21 Magnolia Oil & Gas sees spending 50%-60% of 2021 EBITDA on drilling 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 11/23/20 Magnolia Oil & Gas Chairman Chazen buys over $230K in shares 11/05/20 Magnolia Oil & Gas sees Q4 spending at 55% of adjusted EBITDAX MGY Magnolia Oil & Gas $11.84 / -0.23 (-1.91%) 11/30/20 MKM Partners Magnolia Oil & Gas downgraded to Neutral from Buy at MKM Partners 11/30/20 MKM Partners Magnolia Oil & Gas downgraded to Neutral from Buy at MKM Partners 11/18/20 Piper Sandler Magnolia Oil & Gas price target raised to $6 from $5 at Piper Sandler 11/06/20 Northland Magnolia Oil & Gas upgraded to Outperform from Market Perform at Northland MGY Magnolia Oil & Gas $11.84 / -0.23 (-1.91%) 02/22/21 Magnolia Oil & Gas reports Q4 adjusted EPS 15c, consensus 10c 11/05/20 Magnolia Oil & Gas reports Q3 EPS 5c, consensus 7c 03 Mar

General news	Export Prices data reported. » 19:32 03/02/21 03/02 19:32 03/02/21 19:32 February Export Prices at… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	Import Prices data reported. » 19:32 03/02/21 03/02 19:32 03/02/21 19:32 February Import Prices at… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
On The Fly	Fly Intel: After-Hours Movers » 19:16 03/02/21 03/02 19:16 03/02/21 19:16 MRVI Maravai Lifesciences $35.01 / -1.43 (-3.92%) , AMBA Ambarella $113.78 / -4.91 (-4.14%) , QTRX Quanterix $77.06 / -5.61 (-6.79%) , LYFT Lyft $57.06 / -0.26 (-0.45%) , FUBO FuboTV $41.96 / +3.24 (+8.37%) , BGS B&G Foods $30.44 / -0.36 (-1.17%) , GO Grocery Outlet $36.12 / +0.19 (+0.53%) , VEC Vectrus $55.59 / +0.89 (+1.63%) , ROST Ross Stores $117.75 / -2.63 (-2.18%) , NVEE NV5 Global $102.47 / -2.59 (-2.47%) , REAL RealReal $26.70 / -1.48 (-5.25%) , RVMD Revolution Medicines $44.36 / -1.57 (-3.42%) , JWN Nordstrom $37.45 / -0.5 (-1.32%) , URBN Urban Outfitters $33.75 / -0.4 (-1.17%) , ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) , SSYS Stratasys $32.27 / -4.12 (-11.32%) , ICAD iCAD $18.88 / -0.3 (-1.56%) , ABNB Airbnb $189.68 / -6.16 (-3.15%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRVI AMBA QTRX LYFT FUBO BGS GO VEC ROST NVEE REAL RVMD JWN URBN ARNA SSYS ICAD ABNB MRVI Maravai Lifesciences $35.01 / -1.43 (-3.92%) 02/10/21 Maravai Lifesciences subsidiary issued patent for CleanCap technology 11/30/20 Maravai Lifesciences CEO buys 35K shares of common stock AMBA Ambarella $113.78 / -4.91 (-4.14%) 16:35 Today Ambarella jumps 7% to $121.95 after Q4 results top estimates 05:06 Today Motional selects Ambarella CVflow AI processors for driverless vehicles 01/11/21 Ambarella unveils CV5 AI vision processor with 8K capabilities 12/28/20 FAA adopts final rules for drones 'advancing opportunities' for utilization QTRX Quanterix $77.06 / -5.61 (-6.79%) 02/12/21 Quanterix announces Simoa joint laboratory with WuXi AppTec 01/11/21 Quanterix gets FDA emergency use authorization for COVID protein antigen test 12/28/20 Quanterix gets FDA EUA for COVID antibody test with Simoa 12/24/20 Quanterix gets EUA for Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test LYFT Lyft $57.06 / -0.26 (-0.45%) 16:18 Today Lyft raises Q1 adjusted EBITDA view to ($135M) from ($150M)-($145M) 02/10/21 GM not planning to partner with rideshare players as EV portfolio rolls out 02/09/21 Lyft jumps 5% to $56.50 per share after Q4 results 02/09/21 Lyft reports Q4 active riders 12,552, down 45.2% FUBO FuboTV $41.96 / +3.24 (+8.37%) 16:18 Today FuboTV falls 5% to $39.91 after Q4 earnings miss 16:17 Today FuboTV reports Q4 subscription revenue up 91% to $91.4M 02/22/21 Discovery says recognized 126M total gain on FuboTV investment 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel BGS B&G Foods $30.44 / -0.36 (-1.17%) 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 12/23/20 B&G Foods recalls individual containers of Food Club Garlic Powder 12/01/20 B&G Foods sees accretion from acquisition of J. M. Smucker's Crisco oils 11/16/20 B&G Foods CEO Kenneth Romanzi to step aside, David Wenner named interim CEO GO Grocery Outlet $36.12 / +0.19 (+0.53%) 18:36 Today Grocery Outlet sees FY21 EBITDA margins in line with 2019 performance 16:17 Today Grocery Outlet sees Q1 comparable sales down high single digits 11/10/20 Grocery Outlet to open 34 stores this year, no additional closures planned VEC Vectrus $55.59 / +0.89 (+1.63%) 16:10 Today Vectrus reports backlog as of December 31, 2020, $5.1B 02/15/21 Vectrus awarded prime contract for Department of Defense Naval Base Coronado 01/04/21 Vectrus acquires HHB Systems, terms not disclosed 12/29/20 Vectrus awarded $882.49M Army contract ROST Ross Stores $117.75 / -2.63 (-2.18%) 16:04 Today Ross Stores falls 5% to $111.50 after Q4 earnings miss 16:04 Today Ross Stores reports Q4 SS down 6% 16:02 Today Ross Stores reinstates quarterly dividend of 28.5c per share 02/28/21 Fly Intel: Top five weekend stock stories NVEE NV5 Global $102.47 / -2.59 (-2.47%) 02/22/21 NV5 Global acquires TerraTech Engineers, terms not disclosed 02/11/21 NV5 Global division launches INSITE platform 02/02/21 NV5 Global awarded $5M in South Florida contracts 01/25/21 NV5 Global awarded $100M engineering, design contract REAL RealReal $26.70 / -1.48 (-5.25%) 02/22/21 RealReal sees Q1 gross merchandise volume $301M-$310M 01/13/21 RealReal issues Luxury Consignment Report 12/02/20 RealReal reports approx. 10% y/y increase in 5-day holiday period order volume 12/02/20 RealReal: Business recovery continued in November RVMD Revolution Medicines $44.36 / -1.57 (-3.42%) 10/25/20 Revolution Medicines reports progress, expansion of combo strategy with RMC-4630 10/12/20 Revolution Medicines to present interim fata from Phase 1b/2 trial of RMC-4630 09/16/20 Revolution Medicines reports data on KRAS-G12D(ON) inhibitors JWN Nordstrom $37.45 / -0.5 (-1.32%) 16:20 Today Nordstrom says overall trends improved sequentially throughout the quarter 16:14 Today Nordstrom says taking actions to 'significantly reduce inventory levels' in Q1 16:12 Today Nordstrom says Q4 digital sales of about $2B represented 54% of business 03/01/21 Nordstrom, Tonal form partnership URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 01/12/21 Urban Outfitters drops 11% to $27.00 after posting holiday sales decline 12/03/20 Urban Outfitters appoints Melanie Marein-Efron as CFO 10/13/20 Urban Outfitters announces management changes ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 16:20 Today Arena Pharmaceuticals slides after IBS trial did not meet primary endpoint 16:11 Today Arena Pharmaceuticals reports topline results from Phase 2b CAPTIVATE trial 02/02/21 Arena Pharmaceuticals completes enrollment of ELEVATE UC 52 trial 12/08/20 Arena Pharmaceuticals achieves target enrollment for Phase 3 ELEVATE UC 52 trial SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Stratasys expects Q1 revenue to track similarly to 1Q20 02/18/21 Stratasys acquires U.K.-based RP Support Ltd., terms not stated 02/18/21 Stratasys acquires RPS, provider of best-in-class' stereolithography 3D printers 12/09/20 Stratasys to acquire Origin for total consideration of up to $100M ICAD iCAD $18.88 / -0.3 (-1.56%) 12/29/20 iCAD to partner with Dr. Santosh Kesari evaluating its eBx system to treat GBM 12/10/20 Solis Mammography adopts iCAD's ProFound AI platform 11/30/20 iCAD highlights suite of breast health AI solutions at RSNA 2020 11/25/20 iCAD announces data on treatment of early-stage breast, gynelogical cancers ABNB Airbnb $189.68 / -6.16 (-3.15%) 02/25/21 Airbnb rallies 3% to $186.66 after revenue beats expectations 02/25/21 Airbnb sees 2021 capital expenditures higher than 2020 02/25/21 Airbnb sees adjusted EBITDA margins lower in first half than second 01/13/21 Airbnb to cancel reservations in D.C. area during Inauguration week MRVI AMBA QTRX LYFT FUBO BGS GO VEC ROST NVEE REAL RVMD JWN URBN ARNA SSYS ICAD ABNB MRVI Maravai Lifesciences $35.01 / -1.43 (-3.92%) 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 12/16/20 KeyBanc Maravai Lifesciences initiated with an Overweight at KeyBanc 12/15/20 Morgan Stanley Maravai Lifesciences initiated with an Overweight at Morgan Stanley 12/15/20 Baird Baird starts Maravai Lifesciences at Outperform with $31 price target AMBA Ambarella $113.78 / -4.91 (-4.14%) 02/24/21 Deutsche Bank Ambarella price target raised to $100 from $75 at Deutsche Bank 01/21/21 Stifel Ambarella price target raised to $118 from $110 at Stifel 01/13/21 Roth Capital Ambarella upgraded to Buy with $130 price target at Roth Capital 01/13/21 Roth Capital Ambarella upgraded to Buy from Neutral at Roth Capital QTRX Quanterix $77.06 / -5.61 (-6.79%) 01/27/21 SVB Leerink Quanterix price target raised to $75 from $50 at SVB Leerink 01/14/21 Canaccord Quanterix price target raised to $74 from $60 at Canaccord 01/12/21 Canaccord Quanterix price target raised to $60 from $54 at Canaccord 10/19/20 SVB Leerink Quanterix price target raised to $48 from $37 at SVB Leerink LYFT Lyft $57.06 / -0.26 (-0.45%) 02/11/21 KeyBanc Uber price target raised to $75 from $63 at KeyBanc 02/11/21 Needham Needham transfers coverage on Lyft, raises price target $70 from $50 02/10/21 DA Davidson Lyft price target raised to $66 from $58 at DA Davidson 02/10/21 Jefferies Lyft price target raised to $75 from $70 at Jefferies FUBO FuboTV $41.96 / +3.24 (+8.37%) 02/01/21 Wedbush FuboTV price target raised to $50 from $40 at Wedbush 01/21/21 Barrington FuboTV initiated with an Outperform at Barrington 01/19/21 LightShed Partners FuboTV price target lowered to $6.50 from $8 at LightShed Partners 01/12/21 Roth Capital FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital BGS B&G Foods $30.44 / -0.36 (-1.17%) 01/19/21 Stephens B&G Foods initiated with an Equal Weight at Stephens 01/05/21 Credit Suisse B&G Foods downgraded to Underperform from Neutral at Credit Suisse 07/28/20 Seaport Global B&G Foods initiated with a Neutral at Seaport Global 06/12/20 Fly Intel: Top five analyst initiations GO Grocery Outlet $36.12 / +0.19 (+0.53%) 11/18/20 Berenberg Grocery Outlet initiated with a Buy at Berenberg 11/11/20 DA Davidson Grocery Outlet price target lowered to $50 from $53 at DA Davidson 08/14/20 DA Davidson Grocery Outlet initiated with a Buy at DA Davidson 08/14/20 DA Davidson Grocery Outlet initiated with a Buy at DA Davidson VEC Vectrus $55.59 / +0.89 (+1.63%) 05/19/20 B. Riley FBR B. Riley FBR sees path for Vectrus shares to top $70 03/05/20 B. Riley FBR Vectrus price target raised to $60 from $55 at B. Riley FBR 03/04/20 Noble Capital Vectrus upgraded to Outperform from Market Perform at Noble Capital ROST Ross Stores $117.75 / -2.63 (-2.18%) 01/21/21 Deutsche Bank Ross Stores price target raised to $129 from $123 at Deutsche Bank 01/04/21 JPMorgan Ross Stores price target raised to $128 from $125 at JPMorgan 11/20/20 MKM Partners Ross Stores price target raised to $124 from $105 at MKM Partners 11/20/20 Loop Capital Ross Stores price target raised to $130 from $110 at Loop Capital NVEE NV5 Global $102.47 / -2.59 (-2.47%) 01/13/21 Roth Capital NV5 Global price target raised to $136 from $82 at Roth Capital 11/12/20 Roth Capital NV5 Global price target raised to $82 from $77 at Roth Capital 08/24/20 Fly Intel: Top five analyst upgrades 08/24/20 Sidoti Sidoti upgrades NV5 Global to Buy following pullback REAL RealReal $26.70 / -1.48 (-5.25%) 02/23/21 Fly Intel: Top five analyst downgrades 02/23/21 BTIG RealReal price target raised to $32 from $27 at BTIG 02/23/21 Cowen RealReal price target raised to $29 from $18 at Cowen 02/23/21 Raymond James RealReal downgraded to Market Perform from Outperform at Raymond James RVMD Revolution Medicines $44.36 / -1.57 (-3.42%) 01/29/21 JPMorgan Revolution Medicines price target raised to $44 from $33 at JPMorgan 10/26/20 H.C. Wainwright Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright 09/14/20 Jefferies Inhibrx initiated with a Buy at Jefferies 05/21/20 Fly Intel: Top five analyst initiations JWN Nordstrom $37.45 / -0.5 (-1.32%) 02/16/21 JPMorgan Nordstrom price target raised to $40 from $34 at JPMorgan 02/10/21 Gordon Haskett Nordstrom upgraded to Buy from Hold at Gordon Haskett 01/21/21 Deutsche Bank Nordstrom price target raised to $43 from $24 at Deutsche Bank 01/14/21 Credit Suisse Nordstrom price target raised to $39 from $26 at Credit Suisse URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 02/26/21 Deutsche Bank Urban Outfitters named short-term investment idea at Deutsche Bank 02/10/21 RBC Capital Urban Outfitters price target raised to $30 from $28 at RBC Capital 01/21/21 Deutsche Bank Urban Outfitters price target raised to $32 from $31 at Deutsche Bank 01/14/21 Fly Intel: Top five analyst downgrades ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 01/28/21 JonesTrading Arena Pharmaceuticals initiated with a Buy at JonesTrading 11/19/20 SMBC Nikko Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko 11/10/20 RBC Capital Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital 11/02/20 JPMorgan Arena Pharmaceuticals price target raised to $90 from $71 at JPMorgan SSYS Stratasys $32.27 / -4.12 (-11.32%) 01/19/21 Stifel Stratasys initiated with a Buy at Stifel 01/15/21 JPMorgan Stratasys downgraded to Underweight from Neutral at JPMorgan 10/09/20 Berenberg Stratasys initiated with a Buy at Berenberg 09/24/20 Fly Intel: Top five analyst downgrades ICAD iCAD $18.88 / -0.3 (-1.56%) 02/26/21 B. Riley Securities iCAD price target raised to $23 from $18 at B. Riley Securities 02/25/21 Oppenheimer iCAD initiated with an Outperform at Oppenheimer 02/25/21 Craig-Hallum iCAD price target raised to $22 from $15 at Craig-Hallum 02/25/21 Lake Street iCAD price target raised to $21 from $17 at Lake Street ABNB Airbnb $189.68 / -6.16 (-3.15%) 02/26/21 HSBC Airbnb price target raised to $224 from $220 at HSBC 02/26/21 Jefferies Airbnb price target raised to $210 from $170 at Jefferies 02/26/21 DA Davidson Airbnb price target raised to $210 from $172 at DA Davidson 02/26/21 Needham Airbnb represents 'best way to play travel recovery', says Needham MRVI AMBA QTRX LYFT FUBO BGS GO VEC ROST NVEE REAL RVMD JWN URBN ARNA SSYS ICAD ABNB MRVI Maravai Lifesciences $35.01 / -1.43 (-3.92%) 16:20 Today Maravai Lifesciences sees FY21 EPS 80c-90c, consensus 61c 16:17 Today Maravai Lifesciences reports Q4 EPS 13c, consensus 11c AMBA Ambarella $113.78 / -4.91 (-4.14%) 16:12 Today Ambarella reports Q4 EPS 14c, consensus 8c 11/24/20 Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M 11/23/20 Ambarella reports Q3 EPS 9c, consensus 5c QTRX Quanterix $77.06 / -5.61 (-6.79%) 16:07 Today Quanterix reports Q4 loss from operations ($11.7M) vs. ($10.8M) last year LYFT Lyft $57.06 / -0.26 (-0.45%) 02/09/21 Lyft reports Q4 revenue $569.9M, consensus $562.49M 02/09/21 Notable companies reporting after market close 12/02/20 Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range 11/10/20 Lyft reports Q3 adj. EPS (89c), consensus (91c) FUBO FuboTV $41.96 / +3.24 (+8.37%) 16:16 Today FuboTV raises FY21 revenue view to $460M-$470M from $415M-$435M 16:13 Today FuboTV sees Q1 revenue $101M-$103M, consensus $99.36M 16:12 Today FuboTV reports Q4 EPS ($2.47), consensus (73c) 01/05/21 FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M BGS B&G Foods $30.44 / -0.36 (-1.17%) 16:08 Today B&G Foods sees FY21 revenue roughly $2.05B-$2.1B, consensus $2.03B 16:08 Today B&G Foods reports Q4 adjusted EPS 35c, consensus 44c 11/16/20 B&G Foods backs FY20 adjusted EPS view $2.30-$2.40, consensus $2.33 11/05/20 B&G Foods sees FY20 adjusted EPS $2.30-$2.40, consensus $2.22 GO Grocery Outlet $36.12 / +0.19 (+0.53%) 16:14 Today Grocery Outlet reports Q4 adjusted EPS 24c, consensus 23c 11/10/20 Grocery Outlet reports Q3 adj. EPS 50c, consensus 23c 11/10/20 Notable companies reporting after market close VEC Vectrus $55.59 / +0.89 (+1.63%) 16:09 Today Vectrus sees FY21 adjusted EPS $3.48-$4.08, consensus $3.74 16:07 Today Vectrus reports Q4 adjusted EPS $1.18, consensus 92c 11/10/20 Vectrus backs FY20 adjjusted EPS view $2.68-$2.82, consensus $2.63 11/10/20 Vectrus reports Q3 adjustec EPS 89c, consensus 82c ROST Ross Stores $117.75 / -2.63 (-2.18%) 16:04 Today Ross Stores sees Q1 EPS 74c-86c, consensus 89c 16:02 Today Ross Stores reports Q4 EPS 67c, consensus $1.00 11/19/20 Ross Stores says November month-to-date comps down mid-single-digits 11/19/20 Ross Stores reports Q3 EPS $1.02 excluding 65c charge, consensus 61c NVEE NV5 Global $102.47 / -2.59 (-2.47%) 16:06 Today NV5 Global reports Q4 EPS 82c, consensus 78c 11/11/20 NV5 Global reports Q3 EPS $1.13, consensus 70c REAL RealReal $26.70 / -1.48 (-5.25%) 02/22/21 RealReal reports Q4 EPS (49c), consensus (41c) 02/22/21 Notable companies reporting after market close 11/09/20 Notable companies reporting after market close RVMD Revolution Medicines $44.36 / -1.57 (-3.42%) 16:12 Today Revolution Medicines reports Q4 EPS (52c), consensus (38c) 11/12/20 Revolution Medicines reports Q3 EPS (42c), consensus (39c) JWN Nordstrom $37.45 / -0.5 (-1.32%) 16:09 Today Nordstrom sees FY21 revenue up more than 25%, consensus $13.46B 16:07 Today Nordstrom reports Q4 EPS 21c, consensus 14c 16:05 Today Nordstrom reports Q4 EPS 21c, consensus 14c 02/04/21 Nordstrom gives long-term outlook, sees sales growing low single-digits annually URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 16:08 Today Urban Outfitters reports Q4 EPS 29c, consensus 28c 02/09/21 Urban Outfitters reports preliminary Q4 revenue $1.09B, consensus $1.1B 01/12/21 Urban Outfitters reports total net revenue for 2 months ended Dec 31 down 8.4% 01/12/21 Urban Outfitters reports total net revenue for 2 months ended Dec 31 down 8.4% ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 02/23/21 Arena Pharmaceuticals reports Q4 EPS ($2.10), consensus ($1.85) 11/09/20 Arena Pharmaceuticals reports Q3 EPS ($1.69), consensus ($1.87) SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Stratasys reports Q4 EPS 13c, consensus 0c 11/12/20 Stratasys reports Q3 non-GAAP EPS (5c), consensus (7c) ICAD iCAD $18.88 / -0.3 (-1.56%) 02/24/21 iCAD reports Q4 adjusted EPS (6c), consensus (7c) 11/05/20 iCAD reports Q3 EPS (7c), consensus (11c) ABNB Airbnb $189.68 / -6.16 (-3.15%) 02/25/21 Airbnb sees Q1 revenue down year-over-year 02/25/21 Airbnb reports Q4 revenue $859M, consensus $747.59M 02/25/21 Notable companies reporting after market close 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 03 Mar 03 Mar 04 Feb 04 Feb 30 Dec 10 Dec 20 Nov 08 Oct 13 Aug 07 Aug 09 Jul 28 May 23 Apr LYFT ROST JWN ARNA ABNB LYFT Lyft $57.06 / -0.26 (-0.45%) 01/12/21 Uber, Lyft drivers and union sue over Prop. 22, Axios reports 11/24/20 Uber, Lyft awarded five-year contract by GSA worth up to $810M, Reuters reports 11/23/20 Key Biden technology adviser makes regulation seem more likely, Reuters says 11/07/20 Gig-work companies win in CA, still facing battles elsewhere, Barron's says ROST Ross Stores $117.75 / -2.63 (-2.18%) 02/27/21 Ross Stores stock 'a unique bargain' among discount retailers, Barron's says JWN Nordstrom $37.45 / -0.5 (-1.32%) 01/02/21 Nordstrom looks like a department store survivor, Barron's says ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 11/05/20 Governor Cuomo says NY 'ripe' for pot legalization, amNewYork says 11/04/20 Marijuana legalization measures set to pass in five states, Tech Crunch says ABNB Airbnb $189.68 / -6.16 (-3.15%) 02/05/21 Chobani eyeing IPO, targeting valuation of $7B-$10B, WSJ reports 01/14/21 Airbnb CEO says travel will permanently change due to pandemic, Reuters says 01/10/21 Airbnb Section 230 use underscores law's reach beyond Facebook, WSJ says 12/24/20 Airbnb asked by California counties to halt Lake Tahoe rentals, SFC reports MRVI AMBA QTRX LYFT FUBO BGS GO ROST REAL RVMD JWN URBN ARNA SSYS ABNB MRVI Maravai Lifesciences $35.01 / -1.43 (-3.92%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO AMBA Ambarella $113.78 / -4.91 (-4.14%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 11/23/20 Fly Intel: After-Hours Movers QTRX Quanterix $77.06 / -5.61 (-6.79%) 01/11/21 Fly Intel: After-Hours Movers LYFT Lyft $57.06 / -0.26 (-0.45%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: After-Hours Movers FUBO FuboTV $41.96 / +3.24 (+8.37%) 02/16/21 Fly Intel: After-Hours Movers 01/21/21 FuboTV jumps as Barrington says buy, Einhorn highlights gains 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/12/21 Fly Intel: Wall Street's top stories for Tuesday BGS B&G Foods $30.44 / -0.36 (-1.17%) 10/26/20 Fly Intel: After-Hours Movers GO Grocery Outlet $36.12 / +0.19 (+0.53%) 11/10/20 Fly Intel: After-Hours Movers ROST Ross Stores $117.75 / -2.63 (-2.18%) 11/19/20 Fly Intel: After-Hours Movers 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street REAL RealReal $26.70 / -1.48 (-5.25%) 02/22/21 Fly Intel: After-Hours Movers RVMD Revolution Medicines $44.36 / -1.57 (-3.42%) 02/01/21 Fly Intel: After-Hours Movers JWN Nordstrom $37.45 / -0.5 (-1.32%) 01/14/21 Fly Intel: Pre-market Movers 01/13/21 Fly Intel: After-Hours Movers 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street 11/24/20 Fly Intel: After-Hours Movers URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 02/26/21 Best Buy downgrade among today's top calls on Wall Street 02/09/21 Fly Intel: After-Hours Movers 01/13/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: After-Hours Movers ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday 11/10/20 Fly Intel: Pre-market Movers 11/09/20 Fly Intel: After-Hours Movers SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Fly Intel: Pre-market Movers ABNB Airbnb $189.68 / -6.16 (-3.15%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: After-Hours Movers 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 00:00 Today 41st Annual Healthcare Virtual Conference 00:00 Today Industrial Technologies Virtual Conference 2021 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 16:15 Today Ross Stores - ROST 16:30 Today NV5 Global - NVEE 16:30 Today Ambarella - AMBA 16:30 Today Vectrus - VEC 16:30 Today Grocery Outlet - GO 16:30 Today B&G Foods - BGS 16:30 Today Quanterix - QTRX 16:45 Today Nordstrom - JWN 17:00 Today Maravai Lifesciences - MRVI 17:30 Today FuboTV - FUBO 17:30 Today Urban Outfitters - URBN 03/04/21 B&G Foods MRVI AMBA QTRX LYFT FUBO BGS ROST RVMD JWN URBN SSYS ABNB MRVI Maravai Lifesciences $35.01 / -1.43 (-3.92%) 12/09/20 Nine new option listings on December 9th AMBA Ambarella $113.78 / -4.91 (-4.14%) 02/01/21 Ambarella call volume above normal and directionally bullish 01/21/21 Ambarella call volume above normal and directionally bullish 12/10/20 Ambarella call volume above normal and directionally bullish 12/03/20 Ambarella call volume above normal and directionally bullish QTRX Quanterix $77.06 / -5.61 (-6.79%) 10/21/20 Eleven new option listings and one option delisting on October 21st LYFT Lyft $57.06 / -0.26 (-0.45%) 02/25/21 Lyft call volume above normal and directionally bullish 02/11/21 Unusually active option classes on open February 11th 02/09/21 Lyft options imply 13.2% move in share price post-earnings 01/19/21 Lyft call volume above normal and directionally bullish FUBO FuboTV $41.96 / +3.24 (+8.37%) 01/12/21 Unusually active option classes on open January 12th 01/05/21 Largest borrow rate increases among liquid names 01/04/21 Largest borrow rate increases among liquid names 12/30/20 Unusually active option classes on open December 30th BGS B&G Foods $30.44 / -0.36 (-1.17%) 01/22/21 Largest borrow rate increases among liquid names 12/28/20 Largest borrow rate increases among liquid names 12/08/20 Largest borrow rate increases among liquid names 11/25/20 Largest borrow rate increases among liquid names ROST Ross Stores $117.75 / -2.63 (-2.18%) 11/20/20 Early notable gainers among liquid option names on November 20th 11/19/20 Ross Stores options imply 4.2% move in share price post-earnings RVMD Revolution Medicines $44.36 / -1.57 (-3.42%) 11/25/20 new option listings on November 25th JWN Nordstrom $37.45 / -0.5 (-1.32%) 15:04 Today Nordstrom options imply 13.1% move in share price post-earnings 01/29/21 Nordstrom put buyer realizes 156% same-day gains 01/25/21 Early notable gainers among liquid option names on January 25th 12/31/20 Early notable gainers among liquid option names on December 31st URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 11/10/20 Early notable gainers among liquid option names on November 10th 09/14/20 Early notable gainers among liquid option names on September 14th SSYS Stratasys $32.27 / -4.12 (-11.32%) 02/25/21 Stratasys call volume above normal and directionally bullish 01/07/21 Stratasys call volume above normal and directionally bullish 12/17/20 Stratasys call volume above normal and directionally bullish ABNB Airbnb $189.68 / -6.16 (-3.15%) 11:25 Today Airbnb call volume above normal and directionally bullish 01/14/21 Airbnb call volume above normal and directionally bullish 01/13/21 Option volume wakes up in AirBnB as shares lift 5% 01/12/21 Airbnb call volume above normal and directionally bullish
Syndicate	Indus Realty Trust 1.75M share Secondary priced at $60.00 » 19:01 03/02/21 03/02 19:01 03/02/21 19:01 INDT Indus Realty Trust $60.50 / -1.5 (-2.42%) The deal priced below the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate INDT Indus Realty Trust $60.50 / -1.5 (-2.42%) 01/04/21 INDUS Realty Trust Inc trading resumes 01/04/21 INDUS Realty Trust Inc trading halted, volatility trading pause 01/04/21 Griffin announces name change to Indus Realty Trust 03 Mar
Hot Stocks	SPDR Gold Shares holdings rise to 1,087.12MT from 1,084.50MT » 18:57 03/02/21 03/02 18:57 03/02/21 18:57 GLD SPDR Gold Shares $162.40 / +0.85 (+0.53%) This is the first… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals Options Technical Analysis GLD SPDR Gold Shares $162.40 / +0.85 (+0.53%) 03/01/21 SPDR Gold Shares holdings fall from 1,093.53MT to 1,084.50MT 02/25/21 SPDR Gold Shares holdings fall to 1,100.24MT from 1,106.36MT 02/24/21 SPDR Gold Shares holdings fall to1,106.36MT from 1,110.44MT 02/23/21 SPDR Gold Shares holdings fall to 1,110.44MT from 1,115.40MT GLD SPDR Gold Shares $162.40 / +0.85 (+0.53%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says GLD SPDR Gold Shares $162.40 / +0.85 (+0.53%) 02/26/21 Unusually active option classes on open February 26th 02/22/21 Unusually active option classes on open February 22nd 11/05/20 Unusually active option classes on open November 5th GLD SPDR Gold Shares $162.40 / +0.85 (+0.53%) 02/26/21 On The Fly: ETF fund flow highlights 02/12/21 On The Fly: ETF fund flow highlights 01/15/21 On the Fly: Weekly ETF Fund Flows 11/20/20 On The Fly: ETF fund flow highlights

Syndicate	Autohome announces 27.26M share offering of ordinary shares » 18:49 03/02/21 03/02 18:49 03/02/21 18:49 ATHM Autohome $118.01 / +1.59 (+1.37%) Autohome announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ATHM Autohome $118.01 / +1.59 (+1.37%) 01/12/21 Autohome CEO Min Lu retires, Quan Long succeeds 11/30/20 Autohome falls -8.8% 10/27/20 Autohome announces $168M investment in TTP Car ATHM Autohome $118.01 / +1.59 (+1.37%) 02/03/21 Macquarie Autohome price target raised to $109 from $95 at Macquarie 02/03/21 HSBC Autohome price target raised to $137 from $113 at HSBC 02/03/21 Benchmark Autohome upgraded to Buy from Hold at Benchmark 12/22/20 JPMorgan Latest Georgia polling favors Republicans, says JPMorgan ATHM Autohome $118.01 / +1.59 (+1.37%) 02/02/21 Autohome sees Q1 revenue $277.4M-$282M, two estimates $269.98M 02/02/21 Autohome reports Q4 EPS $1.52, consensus $1.51 11/30/20 Autohome sees Q4 revenue $364.5M-$365.9M, consensus $379.99M 11/30/20 Autohome reports Q3 EPS 1.04, consensus $1.01 ATHM Autohome $118.01 / +1.59 (+1.37%) 11/30/20 Fly Intel: Pre-market Movers
Upgrade	Rapid7 upgraded to Overweight from Neutral at Piper Sandler » 18:43 03/02/21 03/02 18:43 03/02/21 18:43 RPD Rapid7 $79.21 / -2.07 (-2.55%) Piper Sandler analyst Rob… Piper Sandler analyst Rob Owens upgraded Rapid7 to Overweight from Neutral with a $100 price target. ShowHide Related Items >><< Company News Street Research Earnings On The Fly RPD Rapid7 $79.21 / -2.07 (-2.55%) 02/01/21 Rapid7 acquires Kubernetes security provider Alcide for $50M 12/17/20 Rapid7 partners with SCADAfence to provide visibility into OT assets 12/16/20 Rapid7 director sells 20.2K shares of common stock 10/30/20 Rapid7 and Snyk plan to deepen strategic partnership RPD Rapid7 $79.21 / -2.07 (-2.55%) 02/17/21 Stifel Rapid7 resumed with a Buy at Stifel 02/10/21 Morgan Stanley Morgan Stanley downgrades Qualys to Underweight on growth and margin pressures 02/10/21 RBC Capital Rapid7 price target raised to $110 from $105 at RBC Capital 01/27/21 Truist Rapid7 price target raised to $95 from $72 at Truist RPD Rapid7 $79.21 / -2.07 (-2.55%) 02/09/21 Rapid7 sees FY21 EPS (3c)-(4c), consensus 15c 02/09/21 Rapid7 sees Q1 EPS (8c)-(6c), consensus (4c) 02/09/21 Rapid7 reports Q4 EPS (7c), consensus (8c) 11/04/20 Rapid7 sees Q4 EPS (9c)-(7c), consensus (4c) RPD Rapid7 $79.21 / -2.07 (-2.55%) 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack
Recommendations	Target price target lowered to $200 from $220 at Baird » 18:41 03/02/21 03/02 18:41 03/02/21 18:41 TGT Target $173.40 / -12.72 (-6.83%) Baird analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGT Target $173.40 / -12.72 (-6.83%) 13:08 Today Target plans to open five more sortation centers in 2021 13:07 Today Target plans to open 30-40 new stores each year 13:06 Today Target to open approx. 100 Ulta Beauty at Target shop-in-shops in 2021 13:04 Today Target plans to invest $4B annually during next several years TGT Target $173.40 / -12.72 (-6.83%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson TGT Target $173.40 / -12.72 (-6.83%) 06:34 Today Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B TGT Target $173.40 / -12.72 (-6.83%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says TGT Target $173.40 / -12.72 (-6.83%) 16:48 Today Fly Intel: Wall Street's top stories for Tuesday 12:25 Today Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 09:00 Today Target - TGT 09:00 Today Target Corporation TGT Target $173.40 / -12.72 (-6.83%) 09:55 Today Early notable gainers among liquid option names on March 2nd 09:40 Today Unusually active option classes on open March 2nd 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th
Hot Stocks	Welltower and ProMedica announce partnership expansion » 18:41 03/02/21 03/02 18:41 03/02/21 18:41 WELL Welltower $68.68 / +0.15 (+0.22%) , GEN Genesis Healthcare $0.82 / +0.0034 (+0.42%) ProMedica and Welltower… ProMedica and Welltower (WELL) announced two transactions to strengthen and expand their strong existing partnership while maintaining an unwavering focus on patient care and clinical outcomes. The transactions serve to enhance the quality of the Welltower/ProMedica joint venture portfolio and position it for continued growth going forward. First, the JV will divest a 25 property portfolio of non-strategic skilled nursing facilities for $265M. The properties, which were acquired through the formation of the Welltower/ProMedica partnership in 2018, are in eight states and have an average age of 41 years. Second, nine PowerBack rehabilitation facilities, operated by Genesis HealthCare (GEN), will be contributed into Welltower's JV with ProMedica and master leased to ProMedica. The properties are mostly purpose-built state-of-the-art rehabilitation facilities, with numerous amenities. Reimbursements are received primarily from Medicare and commercial insurance providers. ShowHide Related Items >><< Company News Street Research Earnings WELL GEN WELL Welltower $68.68 / +0.15 (+0.22%) 02/16/21 Elliott buys Evergy, exits eBay in Q4 12/15/20 Welltower, Wafra announce $550M medical office building joint venture 12/14/20 Public Storage appoints three independent trustees to board 11/16/20 Paul Singer's Elliott buys Cubic, exits AT&T in Q3 GEN Genesis Healthcare $0.82 / +0.0034 (+0.42%) 01/28/21 Senator Warren sends letter to Genesis over 'inexplicable' bonuses 01/05/21 Genesis Healthcare CEO George Hager retires, Robert Fish to succeed WELL GEN WELL Welltower $68.68 / +0.15 (+0.22%) 02/09/21 Mizuho Welltower price target raised to $60 from $57 at Mizuho 01/26/21 Deutsche Bank Welltower price target lowered to $67 from $71 at Deutsche Bank 01/11/21 BMO Capital Brookdale data supports cautious view on senior housing, says BMO 01/07/21 BMO Capital Welltower downgraded to Underperform from Market Perform at BMO Capital GEN Genesis Healthcare $0.82 / +0.0034 (+0.42%) 01/25/21 Credit Suisse Genesis Healthcare downgraded to Underperform from Neutral at Credit Suisse 08/11/20 Credit Suisse Healthcare Services downgraded to Neutral from Outperform at Credit Suisse WELL WELL Welltower $68.68 / +0.15 (+0.22%) 02/09/21 Welltower sees Q1 EPS 24c-29c, consensus 23c 02/09/21 Welltower reports Q4 normalized FFO 84c, consensus 77c 02/09/21 Welltower sees Q1 normalized FFO 71c-76c, consensus 74c
Hot Stocks	Grocery Outlet sees FY21 EBITDA margins in line with 2019 performance » 18:36 03/02/21 03/02 18:36 03/02/21 18:36 GO Grocery Outlet $36.12 / +0.19 (+0.53%) Says first half of 2021… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GO Grocery Outlet $36.12 / +0.19 (+0.53%) 16:17 Today Grocery Outlet sees Q1 comparable sales down high single digits 11/10/20 Grocery Outlet to open 34 stores this year, no additional closures planned GO Grocery Outlet $36.12 / +0.19 (+0.53%) 11/18/20 Berenberg Grocery Outlet initiated with a Buy at Berenberg 11/11/20 DA Davidson Grocery Outlet price target lowered to $50 from $53 at DA Davidson 08/14/20 DA Davidson Grocery Outlet initiated with a Buy at DA Davidson 08/14/20 DA Davidson Grocery Outlet initiated with a Buy at DA Davidson GO Grocery Outlet $36.12 / +0.19 (+0.53%) 16:14 Today Grocery Outlet reports Q4 adjusted EPS 24c, consensus 23c 11/10/20 Grocery Outlet reports Q3 adj. EPS 50c, consensus 23c 11/10/20 Notable companies reporting after market close 13 Aug 23 Apr GO Grocery Outlet $36.12 / +0.19 (+0.53%) 11/10/20 Fly Intel: After-Hours Movers 16:30 Today Grocery Outlet - GO

Hot Stocks	Crown Castle chairman buys 7.8K shares of common stock » 18:30 03/02/21 03/02 18:30 03/02/21 18:30 CCI Crown Castle $153.18 / -0.63 (-0.41%) In a regulatory filing,… In a regulatory filing, Crown Castle disclosed that its chairman Landis Martin bought 7,765 share of common stock on February 26th in a total transaction size of $1.23M. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CCI Crown Castle $153.18 / -0.63 (-0.41%) 02/26/21 Crown Castle CCO Kavanagh sells nearly 4,000 common shares 12/18/20 Crown Castle releases 2019 corporate sustainability report 11/16/20 Dish signs multiyear anchor tenant tower agreement with Crown Castle 11/09/20 Crown Castle names Chris Levendos as COO - Fiber, effective December 1 CCI Crown Castle $153.18 / -0.63 (-0.41%) 01/14/21 Citi Crown Castle upgraded to Buy from Neutral at Citi 01/11/21 BofA BofA US 1 List changes 01/04/21 LightShed Partners Crown Castle initiated with a Buy at LightShed Partners 12/11/20 Deutsche Bank Crown Castle upgraded to Buy from Hold at Deutsche Bank CCI Crown Castle $153.18 / -0.63 (-0.41%) 01/27/21 Crown Castle,Verizon expand relationship with long term 5G small cell commitment 01/27/21 Crown Castle backs FY21 AFFO view $6.64-$6.74, consensus $6.70 01/27/21 Crown Castle reports Q4 AFFO $2.33, consensus $1.65 01/27/21 Notable companies reporting after market close CCI Crown Castle $153.18 / -0.63 (-0.41%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says CCI Crown Castle $153.18 / -0.63 (-0.41%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 00:00 Today 42nd Annual Institutional Investors Virtual Conference
Initiation	Certara initiated with an Overweight at Barclays » 18:28 03/02/21 03/02 18:28 03/02/21 18:28 CERT Certara $35.32 / -0.72 (-2.00%) Barclays analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Events Options CERT Certara $35.32 / -0.72 (-2.00%) 16:32 Today Barclays Certara initiated with an Overweight at Barclays 01/05/21 Morgan Stanley Morgan Stanley starts Certara at Equal Weight, says fully valued 01/05/21 Morgan Stanley Certara initiated with an Equal Weight at Morgan Stanley 01/05/21 Fly Intel: Top five analyst initiations 11 Dec CERT Certara $35.32 / -0.72 (-2.00%) 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 03/04/21 Certara - CERT CERT Certara $35.32 / -0.72 (-2.00%) 01/28/21 new option listings on January 28th
Initiation	Syneos Health initiated with an Equal Weight at Barclays » 18:25 03/02/21 03/02 18:25 03/02/21 18:25 SYNH Syneos Health $75.44 / -0.79 (-1.04%) Barclays analyst Luke… Barclays analyst Luke Sergott initiated coverage of Syneos Health with an Equal Weight rating and $84 price target. Since the company's merger with InVentiv, investors have been waiting for the synergies to materialize into accelerated topline growth, the analyst tells investors in a research note. Sergott still believes that this will happen, but the transition will take time to materialize and will not be "without bumps in the road". The analyst also states that the group-low valuation for Syneos shares reflects the company's risk profile. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SYNH Syneos Health $75.44 / -0.79 (-1.04%) 02/24/21 Syneos, Protocol First partner to accelerate collection, review of trial data 12/18/20 Syneos Health acquires Illingworth Research Group, terms not disclosed 12/10/20 Syneos Health completes acquisition of Synteract 12/07/20 VBI Vaccines, Syneos Health team for VBI's 3-antigen hep B vaccine SYNH Syneos Health $75.44 / -0.79 (-1.04%) 16:36 Today Barclays Syneos Health initiated with an Equal Weight at Barclays 02/22/21 Mizuho Syneos Health price target raised to $87 from $72 at Mizuho 02/19/21 Citi Syneos Health price target raised to $85 from $80 at Citi 12/09/20 JPMorgan Syneos Health price target raised to $85 from $80 at JPMorgan SYNH Syneos Health $75.44 / -0.79 (-1.04%) 02/18/21 Syneos Health sees FY21 adjusted EPS $4.09-$4.38, consensus $4.23 02/18/21 Syneos Health reports Q4 adjusted EPS $1.11, consensus $1.10 10/29/20 Syneos Health raises FY20 adjusted EPS view to $3.33-$3.46 from $3.16-$3.38 10/29/20 Syneos Health reports Q3 adjusted EPS $1.04, consensus 91c 01 Mar 02 Dec 16 Sep SYNH Syneos Health $75.44 / -0.79 (-1.04%) 09/16/20 Fly Intel: Wall Street's top stories for Wednesday 09/16/20 Fly Intel: Wall Street's top stories at midday 09/16/20 Fly Intel: Pre-market Movers 09/15/20 Fly Intel: After-Hours Movers
Initiation	PPD initiated with an Overweight at Barclays » 18:19 03/02/21 03/02 18:19 03/02/21 18:19 PPD PPD $36.00 / +0.36 (+1.01%) , ICLR Icon $172.19 / -0.78 (-0.45%) Barclays analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events PPD ICLR PPD PPD $36.00 / +0.36 (+1.01%) 02/18/21 PPD awarded US Army study to help develop PTSD drugs 02/09/21 AzurRx BioPharma enters pact with PPD for trial of niclosamide 10/22/20 Moderna says partner PPD 'essential' in Phase 3 Covid study 10/13/20 NeoGenomics to expand global footprint in pharma services ICLR Icon $172.19 / -0.78 (-0.45%) 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/16/21 Icon provided update on its CYTO-200 portfolio of clinical programs 01/04/21 Icon provides trial services to Pfizer, BioNTech COVID-19 vaccine program PPD ICLR PPD PPD $36.00 / +0.36 (+1.01%) 16:35 Today Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi 10/29/20 Deutsche Bank PPD price target raised to $38 from $33 at Deutsche Bank ICLR Icon $172.19 / -0.78 (-0.45%) 18:08 Today Barclays Icon initiated with an Equal Weight at Barclays 16:34 Today Barclays Icon initiated with an Equal Weight at Barclays 03/01/21 UBS Icon upgraded to Buy from Neutral at UBS 03/01/21 UBS Icon upgraded to Buy from Neutral at UBS PPD ICLR PPD PPD $36.00 / +0.36 (+1.01%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B ICLR Icon $172.19 / -0.78 (-0.45%) 02/24/21 Icon sees FY21 adjusted EPS $8.10-$8.50, consensus $7.94 02/24/21 Icon reports Q4 adjusted EPS $1.90, consensus $1.83 10/21/20 Icon raises FY20 revenue view to $6.35-$6.50 from $6.00-$6.50 10/21/20 Icon reports Q3 EPS $1.72, consensus $1.53 17 Sep PPD ICLR PPD PPD $36.00 / +0.36 (+1.01%) 09/14/20 Fly Intel: After-Hours Movers ICLR Icon $172.19 / -0.78 (-0.45%) 02/24/21 Fly Intel: Pre-market Movers 03/03/21 Icon
Periodicals	GM-backed Cruise in talks to acquire Voyage, Bloomberg reports » 18:19 03/02/21 03/02 18:19 03/02/21 18:19 GM General Motors $54.12 / +1.54 (+2.93%) Cruise, the self-driving… Cruise, the self-driving vehicle company majority owned by General Motors, is in discussions to buy Voyage, an autonomous technology startup, Bloomberg's David Welch, Mark Bergen, and Ed Ludlow report, citing people familiar with the matter. The companies are in serious talks, though no agreement is imminent, the authors say. If a deal is reached, it would combine Cruise's engineering and software capabilities with Voyage's presence in the retirement community market, the authors note. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GM General Motors $54.12 / +1.54 (+2.93%) 02/25/21 Caterpillar elects Gerald Johnson to board of directors 02/17/21 EU passenger car registrations down 24.0% in January 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 GM General Motors $54.12 / +1.54 (+2.93%) 02/19/21 Morgan Stanley GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley 02/18/21 Citi General Motors price target raised to $85 from $70 at Citi 02/16/21 Wedbush Wedbush expects Apple to announce formal EV partnership in 2021 02/11/21 RBC Capital General Motors price target raised to $67 from $52 at RBC Capital GM General Motors $54.12 / +1.54 (+2.93%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $54.12 / +1.54 (+2.93%) 18:00 Today GM-backed Cruise in talks to acquire Voyage, Bloomberg reports 02/26/21 GM to furlough workers at Brazil plant for at least 20 days, Reuters reports 02/24/21 GM CFO believes worst of global chip shortage is over, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports GM General Motors $54.12 / +1.54 (+2.93%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 03/05/21 General Motors - GM GM General Motors $54.12 / +1.54 (+2.93%) 12:25 Today General Motors call volume above normal and directionally bullish 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th 01/19/21 Early notable gainers among liquid option names on January 19th

Initiation	Iqvia initiated with an Overweight at Barclays » 18:13 03/02/21 03/02 18:13 03/02/21 18:13 IQV Iqvia $192.72 / -1.69 (-0.87%) Barclays analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options IQV Iqvia $192.72 / -1.69 (-0.87%) 12/21/20 Q2 Solutions teams with Adaptive Biotechnologies to market immunoSEQ Assay 12/16/20 Iqvia in pact with Servier to 'reinvent' its R&D clinical development processes 11/18/20 Iqvia's Rittenmeyer sells over 40,000 common shares 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter IQV Iqvia $192.72 / -1.69 (-0.87%) 16:34 Today Barclays Iqvia initiated with an Overweight at Barclays 02/11/21 Truist Iqvia price target raised to $235 from $197 at Truist 02/11/21 Wells Fargo Iqvia price target raised to $230 from $205 at Wells Fargo 02/11/21 Baird Iqvia price target raised to $221 from $208 at Baird IQV Iqvia $192.72 / -1.69 (-0.87%) 02/10/21 Iqvia raises FY21 adjusted EPS view to $7.77-$8.08 from $7.65-$7.95 02/10/21 Iqvia sees Q1 adjusted EPS $1.81-$1.87, consensus $1.80 02/10/21 Iqvia reports Q4 adjusted EPS $2.11, consensus $2.00 02/09/21 Notable companies reporting before tomorrow's open IQV Iqvia $192.72 / -1.69 (-0.87%) 02/10/21 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: Pre-market Movers 04/13/21 IQVIA Holdings Inc. IQV Iqvia $192.72 / -1.69 (-0.87%) 02/10/21 Early notable gainers among liquid option names on February 10th
Initiation	Icon initiated with an Equal Weight at Barclays » 18:08 03/02/21 03/02 18:08 03/02/21 18:08 ICLR Icon $172.19 / -0.78 (-0.45%) , PRAH PRA Health $142.89 / -1.13 (-0.78%) Barclays analyst Luke… Barclays analyst Luke Sergott initiated coverage of Icon (ICLR) with an Equal Weight rating and $200 price target. The analyst notes that prior to last week's $12B PRA Health (PRAH) acquisition, the company had been "dogmatic" in its M&A approach with bolt-on strategic deals. Sergott adds that while COVID accelerated the need to build data and tech-enabled services at scale, Icon could have likely filled in the gaps via its usual strategy. The analyst further states that Icon's organic growth had been on a decelerating trend over the past couple of years, while its margin profile has been at the bottom of the peer group. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PRAH ICLR PRAH PRA Health $142.89 / -1.13 (-0.78%) 12/17/20 PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program 12/02/20 Appili Therapeutics doses first participant in Avigan trial ICLR Icon $172.19 / -0.78 (-0.45%) 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/16/21 Icon provided update on its CYTO-200 portfolio of clinical programs 01/04/21 Icon provides trial services to Pfizer, BioNTech COVID-19 vaccine program ICLR PRAH ICLR Icon $172.19 / -0.78 (-0.45%) 16:34 Today Barclays Icon initiated with an Equal Weight at Barclays 03/01/21 UBS Icon upgraded to Buy from Neutral at UBS 03/01/21 UBS Icon upgraded to Buy from Neutral at UBS 02/26/21 Truist Icon upgraded to Buy from Hold at Truist PRAH PRA Health $142.89 / -1.13 (-0.78%) 02/25/21 Jefferies PRA Health downgraded to Hold from Buy at Jefferies 02/25/21 Deutsche Bank Icon price target raised to $208 from $179 at Deutsche Bank PRAH ICLR PRAH PRA Health $142.89 / -1.13 (-0.78%) 02/24/21 PRA Health reports Q4 adjusted EPS $1.55, consensus $1.47 11/04/20 PRA Health raises FY20 adj. EPS view to $4.61-$4.71 from $4.35-$4.55 11/04/20 PRA Health reports Q3 adj. EPS $1.30, consensus $1.12 ICLR Icon $172.19 / -0.78 (-0.45%) 02/24/21 Icon sees FY21 adjusted EPS $8.10-$8.50, consensus $7.94 02/24/21 Icon reports Q4 adjusted EPS $1.90, consensus $1.83 10/21/20 Icon raises FY20 revenue view to $6.35-$6.50 from $6.00-$6.50 10/21/20 Icon reports Q3 EPS $1.72, consensus $1.53 ICLR ICLR Icon $172.19 / -0.78 (-0.45%) 02/24/21 Fly Intel: Pre-market Movers 03/03/21 Icon
Periodicals	Goldman Sachs' general counsel, Karen Seymour, to leave, Bloomberg reports » 18:08 03/02/21 03/02 18:08 03/02/21 18:08 GS Goldman Sachs $330.86 / +0.975 (+0.30%) Karen Seymour, Goldman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $330.86 / +0.975 (+0.30%) 08:03 Today Goldman Sachs, Hazeltree partner for streamlined treasury, global payments 02/19/21 Goldman Sachs CFO sells 20K shares of common stock 02/02/21 Goldman Sachs officer Laurence Stein sold almost $3M in company shares 02/01/21 Northrop Grumman announces $2B accelerated share repurchase program GS Goldman Sachs $330.86 / +0.975 (+0.30%) 02/24/21 Wells Fargo Goldman Sachs price target raised to $360 from $335 at Wells Fargo 01/28/21 Deutsche Bank Goldman Sachs price target raised to $310 from $290 at Deutsche Bank 01/22/21 Citi Goldman Sachs price target raised to $370 from $357 at Citi 01/20/21 Credit Suisse Goldman Sachs price target raised to $345 from $325 at Credit Suisse GS Goldman Sachs $330.86 / +0.975 (+0.30%) 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $330.86 / +0.975 (+0.30%) 03/01/21 Goldman reboots crypto trading desk amid institutional interest, Reuters reports 03/01/21 Goldman co-head of asset management leaving firm, Bloomberg reports 03/01/21 Goldman's Omer Ismail leaving to run Walmart's fintech startup, WSJ reports 02/22/21 Toast planning IPO that could value it at around $20B, WSJ reports GS Goldman Sachs $330.86 / +0.975 (+0.30%) 02/05/21 The Intersection: Crypto and Wall Street This Week 01/21/21 Fly Intel: What to watch in IBM's earnings report 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 03/01/21 46th Annual Virtual Conference of AIFA 2021 03/25/21 REITwise 2021 Virtual Conference 04/14/21 Goldman Sachs - GS 03/04/21 Goldman Sachs Group Inc. GS Goldman Sachs $330.86 / +0.975 (+0.30%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Periodicals	Biden's pick for SEC chief gives views on cryptocurrency oversight, Quarts says » 18:06 03/02/21 03/02 18:06 03/02/21 18:06 BTC Bitcoin $0.00 / + (+0.00%) , BITCOIN Bitcoin $0.00 / + (+0.00%) , GBTC Bitcoin Investment Trust $0.00 / + (+0.00%) President Joe… President Joe Biden's pick for the U.S. Securities and Exchange Commission's new chief ,Gary Gensler, gave an indication of his views on cryptocurrency regulation during his confirmation hearing today, wrote Roya Wolverson for Quartz. Gensler said during the Senate Banking Committee hearing, "that while the SEC should promote innovation in blockchain technology, if there are securities involved that trade on exchanges, 'we want to ensure that there's appropriate investor protection," according to the Quartz story. Reference Link ShowHide Related Items >><< Company News Street Research Periodicals On The Fly BTC BTC Bitcoin $0.00 / + (+0.00%) 02/12/21 Twitter CEO, Jay-Z partner to establish bitcoin development fund 02/11/21 BNY Mellon announces formation of new digital assets unit 02/10/21 MasterCard to start support select cryptocurrencies on its network 02/10/21 Twitter CFO to CNBC's 'Squawk Box': Company has studied using bitcoin BTC BITCOIN GBTC BTC Bitcoin $0.00 / + (+0.00%) 01/13/21 Standpoint Research Bitcoin could hit $112,000 this year, says Standpoint Research BITCOIN Bitcoin $0.00 / + (+0.00%) GBTC Bitcoin Investment Trust $0.00 / + (+0.00%) GBTC BTC BITCOIN GBTC Bitcoin Investment Trust $0.00 / + (+0.00%) 01/20/21 Janet Yellen says cryptocurrencies used for illegal financing, BI says 09/29/20 Grayscale now controls roughly 2.4% of total Bitcoin supply, Cointelegraph says BTC Bitcoin $0.00 / + (+0.00%) 03/01/21 Goldman reboots crypto trading desk amid institutional interest, Reuters reports 02/24/21 Square CFO says Cash App saw surge in new bitcoin buyers in January, CNBC says 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 02/15/21 Morgan Stanley investing arm weighs adding Bitcoin to bets list, Bloomberg says BITCOIN Bitcoin $0.00 / + (+0.00%) 02/12/21 Uber would consider accepting bitcoin, CEO tells CNBC BTC BITCOIN BTC Bitcoin $0.00 / + (+0.00%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/26/21 The Intersection: Crypto and Wall Street This Week 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/19/21 The Intersection: Crypto and Wall Street This Week BITCOIN Bitcoin $0.00 / + (+0.00%) 02/17/21 Fly Intel: Wall Street's top stories at midday
Hot Stocks	Mayville Engineering not providing financial outlook for 2021 » 18:02 03/02/21 03/02 18:02 03/02/21 18:02 MEC Mayville Engineering $15.15 / +0.44 (+2.99%) Based on the ongoing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 11/02/20 Mayville Engineering is not providing financial outlook MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 02/04/21 Baird Mayville Engineering price target raised to $20 from $14 at Baird 11/04/20 Citi Mayville Engineering price target raised to $13 from $10 at Citi 08/21/20 Fly Intel: Top five analyst upgrades 08/21/20 UBS Mayville Engineering upgraded to Buy from Neutral at UBS MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 18:02 Today Mayville Engineering reports Q4 pro forma EPS 5c, consensus 1c 11/02/20 Mayville Engineering reports Q3 pro forma EPS (5c), consensus (4c) 03/03/21 Mayville Engineering - MEC

Events

Earnings calls, analyst events, roadshows and more

ASIX
Tomorrow at 00:00

AdvanSix - ASIX Conference Calls
TMO ...
Tomorrow at 00:00

41st Annual Healthcare Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Global High Yield & Leveraged Finance Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Power, Gas, & Solar Leaders Virtual Conference 2021 Conferences

Virtual Conference
Tomorrow at 00:00

2nd Annual Virtual Cannabis 1:1 Conference Conferences

Virtual Conference
Tomorrow at 00:00

30th Global Metals & Mining Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Energy & Power Virtual Conference Conferences

Virtual Conference
EURN ...
Tomorrow at 00:00

15th Annual Capital Link International Shipping Virtual Forum Conferences

Virtual Forum
Tomorrow at 00:00

Microsoft Ignite Conferences

Virtual Event
Tomorrow at 00:00

2021 Canadian Wealth Management Virtual Forum Conferences

Virtual Forum

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim $18.00-18.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan $5.55-5.65 8M Shares PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel $29.00-30.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

MacroGenics price target lowered to $15 from $18 at Citi

TODAY'S FREE FLY STORIES

Get Full Fly Access